{"study_id": 80425, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to summarize the current understanding of melatonin's immunopathogenic characteristics in rheumatoid arthritis (RA), including its controversial proinflammatory and anti-inflammatory effects.", "results_summary": "The study found conflicting evidence on melatonin's role in RA, with some research suggesting it enhances proinflammatory activities, while other studies highlight its anti-inflammatory and immunoregulatory properties. Additionally, melatonin was noted to affect circadian rhythm-related gene expression in RA joints.", "population_specificity": "Preclinical models of arthritis and clinical trials involving inflammatory autoimmune diseases (specific RA patient details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:04.466608+00:00"}
{"study_id": 80436, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to clarify the effects of diet, including melatonin-containing foods, on sleep in healthy adults.", "results_summary": "Foods containing melatonin, such as cherries, were linked to improved sleep outcomes, potentially due to dietary influences on serotonin and melatonin activity.", "population_specificity": "Otherwise healthy adults.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:09.964372+00:00"}
{"study_id": 80433, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to critically assess the quality and reliability of commercial melatonin immunoassays and their use in scientific publications.", "results_summary": "The review found significant variability in the quality of melatonin immunoassays, with many lacking proper validation, specificity, or sensitivity, leading to unreliable results such as overestimation of melatonin levels or unrealistic daytime concentrations.", "population_specificity": "Not specified (focus on assay evaluation, not human subjects)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:11.049075+00:00"}
{"study_id": 80437, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the expression of melatonin and its receptors in human dental pulp and assess melatonin's potential to counteract LPS-induced inflammation in pulpal fibroblasts.", "results_summary": "Melatonin and its receptors (MT1 and MT2) were abundantly expressed in healthy dental pulp, with MT2 expression reduced in inflamed tissue. Melatonin reduced LPS-induced COX-2 and IL-1\u03b2 expression in pulpal fibroblasts, suggesting anti-inflammatory effects.", "population_specificity": "Human dental pulp tissues from healthy teeth and teeth with irreversible pulpitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:11.574719+00:00"}
{"study_id": 80434, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether melatonin supplementation could reduce inflammatory markers (IL-1\u03b2 and TNF-\u03b1) in patients with multiple sclerosis (MS) when added to routine interferon treatment.", "results_summary": "Melatonin significantly reduced IL-1\u03b2 levels in MS patients compared to the placebo group, but no significant effect was observed on TNF-\u03b1 levels. The findings suggest melatonin may have anti-inflammatory benefits in MS by targeting specific cytokines.", "population_specificity": "50 MS patients from the MS Society of Markazi Province, divided into control (placebo) and treatment (melatonin) groups.", "effective_dosage": "3 mg melatonin per day", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:11.765444+00:00"}
{"study_id": 80435, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential benefits of melatonin supplementation on quality of life in elderly patients with metastatic cancer undergoing cytotoxic therapy.", "results_summary": "Melatonin supplementation was associated with improved survival, reduced cancer- and treatment-related symptoms, and enhanced quality of life in older cancer patients. However, no specific studies have been conducted in this population to confirm these effects.", "population_specificity": "Elderly patients with metastatic cancer", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:11.976100+00:00"}
{"study_id": 80438, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the mechanisms by which melatonin inhibits excessive microglial activation and assess its potential for treating diseases related to microglial over-activation.", "results_summary": "The study found that melatonin can detoxify reactive oxygen species (ROS) and prevent microglia from over-activation, demonstrating its feasibility in treating diseases linked to excessive microglial activity.", "population_specificity": "Not specified (review of mechanisms, not a clinical study)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:11.977408+00:00"}
{"study_id": 80439, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 20, "quality_score": 90, "study_goal": "The researchers aimed to determine whether melatonin (3 mg or 10 mg) could reduce persistent postconcussive symptoms (PPCS) in children compared to a placebo.", "results_summary": "Melatonin showed no significant improvement in PPCS symptoms or secondary outcomes (quality of life, cognition, sleep) compared to placebo. Side effects were mild and similar to placebo.", "population_specificity": "Youth aged 8-18 years with PPCS 4-6 weeks after mild traumatic brain injury.", "effective_dosage": "3 mg or 10 mg melatonin (frequency not specified).", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:12.299320+00:00"}
{"study_id": 80440, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the efficacy of pharmacological interventions, including Melatonin, in preventing the onset of new depressive episodes in high-risk adult populations.", "results_summary": "Melatonin was among the pharmacological interventions found to be significantly more effective than placebo in preventing depression, with pooled odds ratios indicating a protective effect. The study did not provide specific efficacy data for Melatonin alone but included it in the overall analysis of effective interventions.", "population_specificity": "Adults with high-risk conditions associated with depression, such as post-stroke or Hepatitis C.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:12.534376+00:00"}
{"study_id": 80441, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential benefits of melatonin in mitigating COVID-19 severity by examining its anti-inflammatory, anti-oxidative, and immune-modulating properties.", "results_summary": "The study suggests melatonin may help reduce excessive inflammation, oxidative stress, and immune overreaction in COVID-19, potentially preventing acute lung injury and improving clinical outcomes. However, further clinical studies are needed to confirm these effects.", "population_specificity": "COVID-19 patients and critical care patients (generalized based on pathogenesis and prior evidence).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:18.055855+00:00"}
{"study_id": 80443, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of QSAR methodologies in developing monoamine oxidase inhibitors, including melatonin, for treating neurodegenerative disorders.", "results_summary": "The abstract does not provide specific findings about melatonin's effects but discusses the broader context of monoamine oxidase inhibitors and their potential in neurodegenerative disease treatment.", "population_specificity": "Not specified (general review of monoamine oxidase inhibitors)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:18.243443+00:00"}
{"study_id": 80445, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of melatonin in treating nocturia in patients with neurological disorders, particularly multiple sclerosis.", "results_summary": "The study found that melatonin was not effective in improving nocturia in multiple sclerosis patients, unlike other treatments such as pelvic floor muscle training, cannabinoids, and desmopressin.", "population_specificity": "Patients with neurological disorders, including multiple sclerosis, Parkinson's disease, stroke, and spinal cord injury.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:19.988590+00:00"}
{"study_id": 80442, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate whether melatonin could protect against radiation-induced DNA double-strand breaks (DSBs) in peripheral blood lymphocytes of patients undergoing abdomen-pelvis CT scans.", "results_summary": "Melatonin significantly reduced \u03b3H2AX-foci, indicating fewer DSBs compared to the placebo group, with no observed side effects at the 100mg dose.", "population_specificity": "Thirty patients undergoing abdomen-pelvis CT examinations.", "effective_dosage": "Single oral dose of 100mg melatonin.", "study_duration": "Single administration 1 hour before the CT scan.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:20.054637+00:00"}
{"study_id": 80448, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review studies on melatonin's effects on cancer stem cells (CSCs) and its potential as a therapeutic solution for cancer treatment challenges posed by CSCs.", "results_summary": "Melatonin was found to promote apoptosis in cancer cells, inhibit tumor metastasis and angiogenesis, and potentially target CSCs, which are resistant to chemotherapy and contribute to cancer recurrence. The review suggests melatonin could address key problems in cancer treatment related to CSCs.", "population_specificity": "Various malignancies, including ovarian, melanoma, colon, and breast cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:20.168892+00:00"}
{"study_id": 80447, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of oral melatonin (2 mg as Circadin) on sleep disturbance and pain intensity in adults with severe non-malignant chronic pain.", "results_summary": "The abstract does not provide results; it describes the study design and planned outcomes.", "population_specificity": "Adults with severe chronic pain (average pain intensity \u22657 on the BPI) from a tertiary referral pain clinic in Northeast Scotland.", "effective_dosage": "2 mg daily (as modified-release Circadin)", "study_duration": "6 weeks per treatment arm, with a 4-week washout period between treatments.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:20.882946+00:00"}
{"study_id": 80444, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review pharmacological treatments for insomnia, including melatonin receptor agonists like ramelteon, and discuss optimal medication choices based on patient characteristics and comorbidities.", "results_summary": "The study found that melatonin receptor agonists, such as ramelteon, are among the preferred agents for treating primary and comorbid insomnia, alongside nonbenzodiazepine sedatives and low-dose doxepin. It also highlighted the need to limit long-term benzodiazepine use due to adverse effects.", "population_specificity": "Patients with primary or comorbid chronic insomnia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:21.218550+00:00"}
{"study_id": 80449, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "To investigate whether adding intravenous melatonin to hypothermia treatment improves neurodevelopmental outcomes in asphyctic newborns.", "results_summary": "The study found that newborns receiving melatonin with hypothermia had significantly higher cognitive scores at 18 months compared to those receiving hypothermia alone, but no differences in motor function assessments. The intervention was deemed feasible with no reported adverse effects.", "population_specificity": "Asphyctic newborns treated in a level 3 neonatal ICU.", "effective_dosage": "5 mg per kg body weight, administered intravenously daily for 3 days.", "study_duration": "3 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:21.525464+00:00"}
{"study_id": 80450, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the bidirectional relationship between migraine and sleep disorders in children, focusing on shared neurochemical systems including melatonin.", "results_summary": "The abstract highlights that melatonin is among the neurochemical systems involved in both migraine pathogenesis and sleep regulation, but no specific results on melatonin's effects are provided.", "population_specificity": "Children with migraine and sleep disorders.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:24.951921+00:00"}
{"study_id": 80452, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential benefits of melatonin in preventing or treating postoperative delirium in older adults.", "results_summary": "The study found some potential benefit with melatonin for postoperative delirium, though further clinical trials are needed to validate these conclusions. No specific efficacy data or statistical significance was detailed in the abstract.", "population_specificity": "Older adults in the peri-operative period.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:27.279443+00:00"}
{"study_id": 80454, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the clinical significance of the serotonin pathway, including melatonin, in carcinoid syndrome, focusing on its role in pathogenesis, diagnosis, prognosis, and therapy.", "results_summary": "The abstract does not provide specific findings about melatonin's effects, only mentioning its role as a biologically active molecule in the serotonin pathway.", "population_specificity": "Patients with neuroendocrine neoplasms and carcinoid syndrome.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:27.285538+00:00"}
{"study_id": 80451, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the acupoint combination effect and biological mechanism of HT 7 and SP 6 in treating insomnia, including the role of melatonin as a secondary outcome measure.", "results_summary": "The study did not report specific findings on melatonin's effects, as it was one of several secondary biomarkers measured in serum. The primary focus was on acupuncture's impact on insomnia symptoms and emotional states.", "population_specificity": "120 patients with insomnia and 10 healthy controls.", "effective_dosage": "Not specified for melatonin.", "study_duration": "2 weeks of intervention with 10 rounds of electroacupuncture.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:27.413120+00:00"}
{"study_id": 80456, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine if serum melatonin levels could predict recovery of consciousness in acute coma patients.", "results_summary": "The study found no significant variation in serum melatonin levels between conscious and non-conscious coma patients, suggesting melatonin was not a predictive biomarker for recovery.", "population_specificity": "75 patients with acute coma.", "effective_dosage": "Not specified", "study_duration": "One-month follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:27.664686+00:00"}
{"study_id": 80453, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize recent advances in neuroinflammation and neurodegeneration related to aging and explore melatonin's potential neuroprotective effects via anti-inflammatory and antioxidative actions at the mitochondrial level.", "results_summary": "The study found that melatonin, along with cannabinoids, exerts beneficial effects on neuroinflammatory processes linked to neurodegenerative diseases like Parkinson's and Alzheimer's, primarily through anti-inflammatory and antioxidative mechanisms at the mitochondrial level. These effects are closely tied to the strategic functions of mitochondria in maintaining cellular redox balance.", "population_specificity": "Not specified (general focus on aging-related neurodegenerative diseases)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:28.166370+00:00"}
{"study_id": 80455, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers explored potential mechanisms, including shifts in melatonin secretion, contributing to residual excessive daytime sleepiness (EDS) in well-treated obstructive sleep apnea (OSA) patients.", "results_summary": "The abstract mentions shifts in melatonin secretion as a possible mechanism for residual EDS in OSA patients but does not provide specific findings on melatonin's effects.", "population_specificity": "Patients with obstructive sleep apnea (OSA) experiencing residual excessive daytime sleepiness despite adherence to positive airway pressure (PAP) therapy.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:28.293999+00:00"}
{"study_id": 80457, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the use of melatonin as a treatment for parasomnias, specifically REM sleep behavior disorder, and its potential to reduce abnormal sleep behaviors and associated risks.", "results_summary": "The study found that melatonin is one of the recommended medicinal treatments for REM sleep behavior disorder, alongside clonazepam, but did not provide specific efficacy data or comparative outcomes. It highlighted the disorder's association with synucleinopathies and high phenoconversion rates to Parkinson's disease.", "population_specificity": "Patients with parasomnias, particularly REM sleep behavior disorder.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:30.955915+00:00"}
{"study_id": 80458, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential effects of melatonin, alone or in combination with anticancer drugs, against glioblastoma (GBM) and summarize its targets, intracellular pathways, and epigenetic activity.", "results_summary": "The study found that melatonin demonstrated antineoplastic effects against GBM, improved patients' quality of life, and showed no significant adverse effects. However, clinical studies were limited in number and sample size.", "population_specificity": "Glioblastoma (GBM) patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:32.272856+00:00"}
{"study_id": 80462, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of melatonin in treating sleep disorders in children and adolescents with autism spectrum disorder (ASD).", "results_summary": "Melatonin showed a large effect size in improving sleep duration (44 minutes longer than placebo) and reducing sleep-onset latency (39 minutes shorter than placebo), based on a meta-analysis of five double-blind RCTs.", "population_specificity": "Children and adolescents with autism spectrum disorder (ASD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:34.678785+00:00"}
{"study_id": 80465, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to investigate the potential of Shimian granules (SMG), an improved formula of Jieyuanshen, to address sleep problems and impaired nighttime alertness in shift nurses.", "results_summary": "The abstract does not provide specific results regarding the effects of SMG or Melatonin.", "population_specificity": "Shift nurses prone to sleep problems and impaired nighttime alertness.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:35.312422+00:00"}
{"study_id": 80461, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate melatonin's effectiveness as a neuroprotective agent for stroke treatment by reviewing clinical and pre-clinical evidence, comparing doses used in RCTs, and assessing translational applicability to humans.", "results_summary": "The study found insufficient RCTs to conclusively prove melatonin's value in stroke patients, but evidence was promising, particularly in reducing oxidative response and increasing survival rates. Translational doses from animal studies were higher than those used in human RCTs.", "population_specificity": "Stroke patients (human and pre-clinical animal models).", "effective_dosage": "Not specified (translational doses were higher than those used in RCTs).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:35.902620+00:00"}
{"study_id": 80459, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To determine whether cataract surgery modifies melatonin secretion at 3 months post-surgery in adult patients.", "results_summary": "Cataract surgery significantly increased urinary melatonin excretion compared to the control group, particularly with clear intraocular lenses (IOLs), but no significant difference was found between clear and yellow IOLs.", "population_specificity": "Adults aged 60+ with grade 2 or higher nuclear cataracts and no prior cataract surgery.", "effective_dosage": "Not specified", "study_duration": "3 months post-surgery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:36.065779+00:00"}
{"study_id": 80464, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and safety of melatonin and memantine in alleviating cognitive disorders in MDD patients undergoing ECT.", "results_summary": "Melatonin (3 mg/d) significantly decreased MMSE and item 3MMSE scores compared to baseline, indicating worsened cognitive function, while memantine improved scores. No adverse effects leading to withdrawal were reported.", "population_specificity": "MDD patients undergoing ECT (22 females, 18 males).", "effective_dosage": "3 mg/d (tablet).", "study_duration": "From the first day of ECT to the sixth session.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:36.358834+00:00"}
{"study_id": 80463, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compile existing knowledge on the molecular mechanisms of melatonin's antimetastatic effects on skeletomuscular sarcomas, particularly in children and adolescents, and explore its potential as an adjuvant therapy.", "results_summary": "Melatonin exhibits significant apoptotic, angiogenic, oncostatic, and antiproliferative effects on various cancer cells, particularly skeletomuscular sarcomas. It shows promise as an adjuvant therapy to enhance the antimetastatic effects of chemotherapeutic drugs.", "population_specificity": "Children, teenagers, and young adults affected by skeletomuscular sarcomas (e.g., osteosarcoma and Ewing sarcoma).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:36.563739+00:00"}
{"study_id": 80467, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize recent findings on the functional roles and therapeutic potentials of melatonin and circadian rhythms in liver diseases.", "results_summary": "Melatonin demonstrated strong antioxidant effects, protecting against oxidative stress-induced liver damage and improving liver conditions. Additionally, it showed various other beneficial effects beyond antioxidant properties, suggesting its potential as a therapeutic strategy for liver diseases.", "population_specificity": "Not specified (review of existing studies on liver diseases and melatonin).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:39.504955+00:00"}
{"study_id": 80471, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to examine emerging and novel neuroprotective interventions, including melatonin, for perinatal brain injury.", "results_summary": "The abstract does not provide specific findings about melatonin's effects, only mentioning it as a novel intervention currently in trials.", "population_specificity": "Premature and term infants with perinatal brain injury.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:42.529140+00:00"}
{"study_id": 80470, "supplement_id": 1328, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "To evaluate pharmacologic and nonpharmacologic strategies, including melatonin, for treating sleep disturbances in children and adolescents with autism spectrum disorder (ASD).", "results_summary": "Melatonin was recommended as a treatment option when behavioral strategies were insufficient, starting with a low dose. The study noted potential adverse effects and lack of long-term safety data but reported no serious adverse events.", "population_specificity": "Children and adolescents with autism spectrum disorder (ASD) and sleep disturbances.", "effective_dosage": "Low dose (specific amount not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:43.306828+00:00"}
{"study_id": 80469, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether adding melatonin to induction of labour (IOL) protocols could reduce the need for caesarean sections.", "results_summary": "The abstract does not provide results regarding melatonin's effects, as it describes a planned study rather than completed findings.", "population_specificity": "Women undergoing induction of labour at term.", "effective_dosage": "Four doses of 10 mg melatonin (first dose in the evening at the time of cervical balloon or Dinoprostone PGE).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:43.408732+00:00"}
{"study_id": 80468, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To determine the clinical and histological effects of a 3-in-1 night facial serum (containing melatonin) on signs of skin aging.", "results_summary": "The serum significantly improved skin texture, pigmentation, erythema, tone, complexion, lines, and wrinkles, with notable reductions in photodamage and hyperpigmentation. Effects were more pronounced after 24 weeks compared to 12 weeks.", "population_specificity": "24 subjects (with 12 continuing to 24 weeks)", "effective_dosage": "Not specified", "study_duration": "12 weeks (24 weeks for extension study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:43.505863+00:00"}
{"study_id": 80472, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin's role in human reproductive function, its antioxidative effects, and its potential clinical applications in improving assisted reproductive technology (ART) outcomes and preventing ovarian aging.", "results_summary": "Melatonin was found to protect ovarian follicular fluid and oocytes from oxidative damage, enhance oocyte maturation, fertilization, and embryo development, and potentially improve ART outcomes. Clinical research also suggests melatonin may have anti-aging benefits and reduce ovarian aging.", "population_specificity": "Patients suffering from infertility, particularly those undergoing ART such as IVF-ET.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:44.916307+00:00"}
{"study_id": 80473, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore how gut dysbiosis and mitochondrial dysfunction interact, particularly focusing on the role of melatonin in regulating mitochondrial function and circadian rhythms.", "results_summary": "The study found that melatonin positively regulates mitochondrial oxidative phosphorylation and mitigates the negative effects of gut-mediated increases in ceramide on mitochondrial function. Melatonin's synthesis in mitochondria is linked to improved mitochondrial function, suggesting therapeutic potential across psychiatric and medical conditions.", "population_specificity": "Not specified (broad relevance to psychiatric and wider medical conditions).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:44.973965+00:00"}
{"study_id": 80474, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic potential of melatonin in managing cardiovascular risk factors and diseases by reviewing existing data and experiments.", "results_summary": "The study found that melatonin has beneficial effects in preventing and improving cardiovascular risk factors, including diabetes, hypertension, hyperlipidemia, obesity, and myocardial ischemia-reperfusion injury, through its antioxidant and regulatory mechanisms.", "population_specificity": "Mammals (primarily human-focused studies inferred from cardiovascular disease context)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:46.637194+00:00"}
{"study_id": 80475, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 40, "study_goal": "The researchers aimed to evaluate the potential role of melatonin as a preventive treatment option for refractory chronic cluster headache when first-line treatments fail.", "results_summary": "The study mentions melatonin as an option with lower levels of evidence for cluster headache prevention when verapamil, lithium, and topiramate are ineffective, but no specific efficacy data or outcomes are provided.", "population_specificity": "Patients with refractory chronic cluster headache.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:49.268577+00:00"}
{"study_id": 80466, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of melatonin and ramelteon in preventing sleep disturbances and delirium in ICU patients.", "results_summary": "The study found that melatonin and ramelteon supplementation may reduce delirium incidence and severity by addressing sleep disturbances, potentially decreasing mechanical ventilation time and the need for psychoactive substances in ICUs. However, further studies with larger participant numbers are needed to confirm these effects.", "population_specificity": "Intensive care unit (ICU) patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:49.575183+00:00"}
{"study_id": 80477, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether melatonin could counteract the negative effects of leptin on sperm quality and oxidative stress in rats.", "results_summary": "Melatonin supplementation prevented the adverse effects of leptin on sperm concentration, morphology, oxidative stress markers, and DNA fragmentation in rats. It also mitigated leptin-induced changes in antioxidant and respiratory chain enzyme expression in the testes.", "population_specificity": "Normal weight rats treated with leptin.", "effective_dosage": "Not specified", "study_duration": "Six weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:50.343270+00:00"}
{"study_id": 80476, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of dietary melatonin in mitigating age-related skeletal muscle disorders and its impact on physical performance, including its role in the gut-muscle axis.", "results_summary": "The study highlights melatonin's anti-aging, anti-inflammatory, and antioxidant properties, particularly its mitochondrial benefits, as effective in reducing skeletal muscle frailty and enhancing physical performance in cellular, preclinical, and clinical studies. It also suggests potential benefits of melatonin on the gut microbiota.", "population_specificity": "Aging individuals with skeletal muscle disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:51.012004+00:00"}
{"study_id": 80478, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 50, "quality_score": 80, "study_goal": "To determine the feasibility of a trial using oral melatonin 5 mg nightly for five nights to treat delirium in older medical inpatients and assess the required sample size for a statistically significant reduction in delirium severity.", "results_summary": "Melatonin showed no adverse effects, but the mean change in delirium severity (MDAS) was not significantly different between the melatonin and placebo groups. A larger trial with 120 participants is suggested to detect a clinically meaningful effect.", "population_specificity": "Older inpatients (\u226570 years) with hyperactive or mixed delirium in a general internal medicine unit.", "effective_dosage": "5 mg nightly", "study_duration": "Five nights", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:52.068070+00:00"}
{"study_id": 80481, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to elucidate the common molecular mechanisms by which melatonin and vitamin D might synergistically protect mitochondrial functioning.", "results_summary": "The study found that melatonin and vitamin D share roles in mitochondrial homeostasis, reducing oxidative stress, inflammation, and mitochondrial dysfunction, with potential benefits for cardiovascular, neurodegenerative, and metabolic diseases.", "population_specificity": "General aging population with potential deficiencies in melatonin and vitamin D.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:53.672456+00:00"}
{"study_id": 80480, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether melatonin functions as an inhibitor of cytosolic glycolysis in cancer cells, potentially halting proliferation, reducing metastasis, and promoting apoptosis.", "results_summary": "The study hypothesizes that melatonin inhibits cytosolic glycolysis in cancer cells by downregulating pyruvate dehydrogenase kinase, shifting ATP synthesis to mitochondrial oxidative phosphorylation, thereby reducing cancer cell proliferation and metastasis. It also suggests melatonin may re-sensitize chemotherapy-resistant tumors to treatment.", "population_specificity": "Experimental cancer models (not specified if human or animal).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:53.890720+00:00"}
{"study_id": 80479, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the long-term safety and efficacy of pediatric prolonged-release melatonin (PedPRM) for treating insomnia in children with autism spectrum disorder, focusing on sleep, growth, and pubertal development.", "results_summary": "PedPRM maintained improvements in sleep disturbance, caregiver satisfaction, and quality of life over 104 weeks, with no significant safety concerns or detrimental effects on growth or puberty. Adverse events were mild and infrequent.", "population_specificity": "Children and adolescents (2-17.5 years old) with autism spectrum disorder (96%) and insomnia.", "effective_dosage": "2 mg, 5 mg, or 10 mg nightly", "study_duration": "104 weeks (2 years)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:53.918473+00:00"}
{"study_id": 80483, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to discuss the role of melatonin in nocturia as part of a broader exploration of its pathophysiology.", "results_summary": "The abstract does not provide specific findings on melatonin's effects, only stating that translational science may improve treatment strategies for nocturia.", "population_specificity": "Not specified (general discussion on nocturia pathophysiology).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:56.552616+00:00"}
{"study_id": 80484, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to review and analyze the relationship between sleep difficulties and autism spectrum disorder (ASD) symptoms, emphasizing the role of sleep in brain and neural development.", "results_summary": "The review highlights that sleep problems are associated with increased ASD symptoms and underscores the importance of addressing sleep issues in ASD individuals, though it does not specifically evaluate Melatonin's effects.", "population_specificity": "Children with autism spectrum disorder (ASD)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:57.521414+00:00"}
{"study_id": 80482, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of melatonin pre-treatment for successful completion of Auditory Brainstem Response (ABR) testing in pediatric patients and assess dosing protocols.", "results_summary": "Melatonin pre-treatment showed success rates ranging from 65% to 86.7% in pediatric ABR testing, with no significant adverse events reported across varying dosages. The study concluded that melatonin may be a useful alternative to sedation for non-sedated ABR testing.", "population_specificity": "Pediatric patients (<18 years), ranging from 1 month to 14 years, 6 months.", "effective_dosage": "0.25 mg for patients <3 months to 20 mg for patients >6 years, with one study using a weight-based approach.", "study_duration": "Not specified (single pre-treatment dose for ABR testing).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:58.319086+00:00"}
{"study_id": 80487, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine melatonin's role in preventing or altering the course of neurodegenerative disorders by focusing on its influence on transcription factors.", "results_summary": "The study highlights melatonin's ability to influence transcription factors involved in neuronal and glial gene expression, suggesting potential benefits for neuronal survival and differentiation in neurodegenerative diseases. It also discusses therapeutic implications and limitations of melatonin's applications.", "population_specificity": "Mammals (including humans), with a focus on neurodegenerative disease models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:59.577975+00:00"}
{"study_id": 80485, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to reconcile conflicting data on melatonin's metabolic effects and propose a framework to understand its role in glycemic health and disease.", "results_summary": "The study highlights confusion in the literature regarding melatonin's metabolic effects, suggesting that the timing of melatonin exposure relative to glycemic challenges is crucial for understanding its impact. It proposes a time-based framework to reconcile paradoxical findings.", "population_specificity": "Not specified (general discussion of melatonin's metabolic effects)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:59.615285+00:00"}
{"study_id": 80490, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of interventions, including Melatonin, for improving sleep in individuals with Angelman Syndrome.", "results_summary": "The review found mixed outcomes for Melatonin's effectiveness in treating sleep problems in Angelman Syndrome, with pharmacological interventions showing both positive and mixed results. Behavioral interventions, either alone or combined with pharmacological treatments, showed positive outcomes but were based on weak evidence.", "population_specificity": "Individuals with Angelman Syndrome (54 participants across 10 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:01.282250+00:00"}
{"study_id": 80488, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to determine whether pharmacological intervention targeting melatonin receptors (using Agomelatine) could reduce OCD symptoms, particularly in patients with sleep and circadian disruptions.", "results_summary": "Seven cases with pre-treatment sleep/circadian disruptions showed OCD symptom reductions (46%-90%), while three cases without such disruptions did not respond to Agomelatine. The study suggests a potential link between sleep/circadian interventions and OCD symptom improvement.", "population_specificity": "Treatment-resistant OCD patients, some with sleep/circadian disruptions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:01.929988+00:00"}
{"study_id": 80489, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether melatonin could effectively prevent radiation-induced oral mucositis in head and neck cancer patients undergoing radiotherapy.", "results_summary": "Melatonin administration (20 mg) alongside conventional treatment reduced severe oral mucositis incidence (5% vs. 30% in controls), decreased pain scores, and preserved salivary antioxidant capacity compared to controls.", "population_specificity": "Forty head and neck cancer patients undergoing radiotherapy at a university hospital in Egypt.", "effective_dosage": "20 mg melatonin (frequency not specified).", "study_duration": "Six weeks (assessed at three and six weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:02.902584+00:00"}
{"study_id": 80491, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to systematically review the ability of food sources of melatonin, such as milk and cherry juice, to promote healthy sleep in humans.", "results_summary": "The study found that consumption of milk and sour cherries, which are sources of melatonin, may improve sleep quality in humans, though limitations included lack of homogeneity in treatment dosage and duration. The results suggest potential suitability of these foods as adjuvants in preventing and treating sleep disorders.", "population_specificity": "Children, adults, and elderly subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:03.828287+00:00"}
{"study_id": 80493, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential role of melatonin in preventing doxorubicin-induced cardiotoxicity.", "results_summary": "Melatonin co-administration reversed doxorubicin-induced cardiotoxicity, reducing mortality, biochemical and histopathological changes, and improving heart function through antioxidant, anti-apoptotic, anti-inflammatory, and mitochondrial protective mechanisms.", "population_specificity": "Not specified (animal or human studies inferred from abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:05.552093+00:00"}
{"study_id": 80492, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the role of melatonin in immune processes relevant to experimental autoimmune encephalomyelitis (EAE), multiple sclerosis (MS), and current clinical trials of melatonin supplementation in MS patients.", "results_summary": "The abstract highlights melatonin's pleiotropic effects, including immunomodulating properties, and suggests its dysregulation is linked to autoimmune diseases like MS. It proposes melatonin as a potential therapeutic target for MS, based on evidence of dysregulated secretion in patients.", "population_specificity": "MS patients and experimental models (EAE).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:05.610992+00:00"}
{"study_id": 80494, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to summarize melatonin's anti-osteosarcoma effects, its underlying molecular mechanisms, and its potential as an adjuvant therapy to improve clinical outcomes in osteosarcoma patients.", "results_summary": "Melatonin demonstrated anti-osteosarcoma properties, including antioxidant activity, anti-proliferation, apoptosis induction, and inhibition of invasion and metastasis. It also showed potential to enhance chemotherapy effects and reduce adverse outcomes.", "population_specificity": "Adolescents with osteosarcoma, particularly those aged 11-15 years.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:06.921889+00:00"}
{"study_id": 80495, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of add-on ramelteon on sleep and circadian rhythm disturbances in patients with schizophrenia.", "results_summary": "The study found that add-on ramelteon significantly increased night-time melatonin levels, improved sleep quality (reduced PSQI scores), increased urinary melatonin and serum AANAT levels, and improved PANSS scores, with greater effects in patients with predominantly negative symptoms.", "population_specificity": "120 patients with schizophrenia, categorized into predominantly positive or negative symptom groups based on PANSS scoring.", "effective_dosage": "Not specified in the abstract.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:07.443132+00:00"}
{"study_id": 80496, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review how anesthesia, surgery, and intensive care disrupt circadian rhythms, including melatonin release, and explore interventions to restore normal rhythms.", "results_summary": "The study found that surgery alters the circadian release of melatonin, among other hormones, and suggests therapies to re-establish normal rhythms, though specific melatonin efficacy is not detailed.", "population_specificity": "Postoperative and intensive care patients.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:08.060755+00:00"}
{"study_id": 80497, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review potential neuroprotectants, including melatonin, for preventing ethanol-induced oxidative stress and neurodegeneration in adolescent models of alcohol use disorders.", "results_summary": "The abstract highlights melatonin as a powerful ROS scavenger with potential clinical relevance in treating alcohol use disorders, though most studies were conducted in adult animal models under forced ethanol paradigms.", "population_specificity": "Adolescent animal models (though most studies reviewed used adult animals).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:09.319249+00:00"}
{"study_id": 80499, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to investigate the effects of melatonin on signaling pathways and molecules involved in the progression of glioma.", "results_summary": "Melatonin was found to regulate biological rhythms and inhibit the proliferation of malignant glioma cells through antioxidant and anti-apoptotic effects. It was also considered in biological processes and signaling pathways involved in glioma development.", "population_specificity": "Glioblastoma (brain tumor) patients, specifically focusing on glioblastoma stem-like cells.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:10.828633+00:00"}
{"study_id": 80498, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the bidirectional relationship between disrupted circadian rhythms and alcohol use disorders (AUD), focusing on melatonin's role in acute alcohol intake, AUD, withdrawal, and abstinence.", "results_summary": "The study found that acute alcohol intake alters melatonin secretion in a dose-dependent manner, with normalization the next morning. Chronic alcohol use disrupts melatonin rhythms, with an inverted diurnal/nocturnal secretion ratio (N/D < 1) serving as a marker of chronic use. Melatonin disruption can persist for 3-12 weeks post-abstinence.", "population_specificity": "Individuals with acute alcohol intake, AUD, withdrawal, and abstinence.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:12.114473+00:00"}
{"study_id": 80500, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential role of melatonin in managing colorectal cancer, focusing on its anticancer properties and ability to modulate chemotherapy toxicity.", "results_summary": "Melatonin demonstrated anticancer activity through multiple signaling pathways and showed potential in reducing chemotherapy toxicity while improving therapeutic efficacy. The study highlights melatonin's antioxidant, immune-stimulant, and antimutagenic properties as beneficial in colorectal cancer treatment.", "population_specificity": "Colorectal cancer patients (not specified further).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:12.925673+00:00"}
{"study_id": 80502, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to systematically review the impact of melatonin on fibromyalgia symptoms, including disease impact, pain, sleep quality, and other related factors.", "results_summary": "All included studies reported positive effects of melatonin on fibromyalgia symptoms, with no major adverse events reported. However, significant heterogeneity between studies was noted, indicating a need for further high-quality trials.", "population_specificity": "Fibromyalgia patients (98 participants across four studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:13.102939+00:00"}
{"study_id": 80503, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review melatonin's roles in pregnancy and lactation, focusing on its potential as a reprogramming therapy to prevent cardiovascular and neurological diseases in offspring.", "results_summary": "The study highlights melatonin's pleiotropic effects in pregnancy and fetal development, supporting its potential as a reprogramming strategy to prevent developmental programming of diseases, though clinical recommendations for pregnant or lactating women are not yet established.", "population_specificity": "Pregnant and lactating women, and their offspring (based on animal studies and clinical evidence).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:14.741535+00:00"}
{"study_id": 80505, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of melatonin preconditioning to enhance the therapeutic effects of mesenchymal stem cell (MSC)-based therapy for kidney disease by improving MSC survival and function in hostile microenvironments.", "results_summary": "The study suggests that melatonin preconditioning may optimize MSC response to harsh kidney disease microenvironments by leveraging its antioxidant and anti-inflammatory properties, potentially improving therapeutic outcomes for acute and chronic kidney disease.", "population_specificity": "Animal models (not specified further)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:14.891560+00:00"}
{"study_id": 80508, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to review melatonin's potential to prevent nephrotoxicity induced by nephrotoxic drugs, focusing on oxidative stress, inflammation, and apoptosis.", "results_summary": "Melatonin effectively reduced oxidative stress by neutralizing free radicals and boosting antioxidant enzymes, mitigated inflammation by inhibiting pro-inflammatory cytokines like TNF-\u03b1 and NF-\u03baB, and supported cellular repair mechanisms, demonstrating comprehensive nephroprotection.", "population_specificity": "Elderly population and individuals with drug-induced nephrotoxicity (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:17.243217+00:00"}
{"study_id": 80506, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate whether melatonin as an add-on treatment with lithium and risperidone improves acute manic episodes in bipolar disorder patients.", "results_summary": "Melatonin significantly improved manic symptoms (measured by YMRS) and overall clinical status (measured by CGI-I) compared to placebo, with statistically significant results (P = 0.021 and P = 0.018, respectively).", "population_specificity": "Patients with bipolar disorder experiencing acute manic episodes.", "effective_dosage": "6 mg/day melatonin, 3 mg/day risperidone, and 900 mg/day lithium.", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:17.277019+00:00"}
{"study_id": 80509, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the clinical effectiveness and safety of pharmacological and non-pharmacological interventions, including melatonin, for adults with insomnia.", "results_summary": "Melatonin showed consistent evidence of effectiveness across multiple outcomes based on more than one high- or moderate-quality review with meta-analysis, though harms data for pharmacological interventions were limited.", "population_specificity": "Adults with insomnia", "effective_dosage": "Not specified", "study_duration": "Short term (<16 weeks)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:17.656987+00:00"}
{"study_id": 80510, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic potential of melatonin in treating age-related ocular diseases such as uveitis, glaucoma, age-related macular degeneration, and diabetic retinopathy.", "results_summary": "The study found that melatonin may protect ocular tissues by reducing free radicals and pro-inflammatory mediators, and it appears safe and well-tolerated even at high doses with no reported adverse effects. Literature suggests melatonin could be a promising pharmacological candidate for ocular diseases, either alone or in combination with other drugs.", "population_specificity": "Age-related ocular disease patients (e.g., uveitis, glaucoma, age-related macular degeneration, diabetic retinopathy).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:20.527277+00:00"}
{"study_id": 80511, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to assess the evidence for adverse events (AEs) associated with short-term and longer-term melatonin treatment for sleep disorders.", "results_summary": "The study found that melatonin was generally safe and well tolerated, with few mild to moderate adverse events reported. No life-threatening or clinically significant AEs were identified, but long-term safety data were limited.", "population_specificity": "Subjects with primary or secondary sleep disorders, excluding pre-term infants and non-English studies.", "effective_dosage": "Daily doses ranged from 0.15 mg to 12 mg.", "study_duration": "Up to 29 weeks, though most studies were shorter (4 weeks or less).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:21.290148+00:00"}
{"study_id": 80512, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review melatonin's biological and chemical properties, its experimental effects, and its clinical impact on patients with neurological disorders.", "results_summary": "The study found that melatonin has strong antioxidant, anti-inflammatory, and immunosuppressive properties, which may play a role in the pathophysiological mechanisms of neurological diseases. Clinical trials showed successful results, suggesting melatonin may have both preventive and therapeutic effects on neurological disorders.", "population_specificity": "Patients with neurological diseases (e.g., Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, Huntington's disease, epilepsy, headache).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:21.481742+00:00"}
{"study_id": 80514, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the main molecular targets of melatonin in leukemia models and its potential as a therapeutic agent.", "results_summary": "The study found that melatonin exhibits anticancer properties such as pro-oxidation, apoptosis induction, antiangiogenesis, and metastasis inhibition, suggesting its potential in leukemia therapy. It also noted melatonin's protective effects on normal bone marrow cells.", "population_specificity": "Leukemia models (not specified if human or animal).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:21.737198+00:00"}
{"study_id": 80515, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore the relationship between sleep disorders and musculoskeletal diseases (MD) and summarize therapeutic approaches, including behavioral and drug therapies.", "results_summary": "The abstract discusses the bidirectional relationship between sleep disorders and MD, highlighting the role of inflammatory markers and lifestyle changes in therapy, but does not specifically address melatonin's effects.", "population_specificity": "Patients with musculoskeletal diseases (MD) experiencing sleep disorders.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:21.805885+00:00"}
{"study_id": 80518, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the relationship between circadian rhythm disorders, melatonin, and glaucoma progression, identifying potential therapeutic targets.", "results_summary": "The study found that circadian-related melatonin and sleep disorders affect intraocular pressure and ocular perfusion pressure, contributing to glaucoma progression. Additionally, glaucoma-induced impaired light perception can disrupt melatonin levels, further misaligning circadian rhythms.", "population_specificity": "Individuals with glaucoma and circadian rhythm disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:24.807087+00:00"}
{"study_id": 80519, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate melatonin's potential therapeutic effects in diabetes mellitus (DM), focusing on its antioxidant properties and ability to mitigate oxidative stress-related complications.", "results_summary": "Melatonin was found to ameliorate oxidative stress caused by reactive oxygen species (ROS) and nitrogen oxidative species (NOS), reducing cellular apoptosis and promoting antioxidant production, thereby potentially mitigating diabetic complications like neuropathy, retinopathy, and nephropathy.", "population_specificity": "Patients with diabetes mellitus (DM) and associated complications (e.g., neuropathy, retinopathy, nephropathy).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:28.509314+00:00"}
{"study_id": 80521, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore the biological underpinnings of borderline personality disorder (BPD), including potential links to melatonin synthesis alterations.", "results_summary": "The abstract suggests that BPD symptom exacerbations may be linked to cyclical variations in estrogen, which in turn decrease serotonin and local melatonin synthesis, overlapping with conditions like migraine and endometriosis.", "population_specificity": "Individuals with borderline personality disorder (BPD).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:28.705465+00:00"}
{"study_id": 80520, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore how melatonin pathways interact with gut-mediated changes in brain development, particularly in Autism Spectrum Disorders (ASD).", "results_summary": "The study found that alterations in melatonin synthesis contribute to hyperserotonemia in ASD, affecting mitochondrial function and exosome content. Melatonin, along with sodium butyrate, was highlighted as a potential treatment for ASD-related symptoms.", "population_specificity": "Individuals with Autism Spectrum Disorders (ASD) and related developmental conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:29.071499+00:00"}
{"study_id": 80523, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of melatonin in addressing circadian dysregulation, inflammation, and behavioral changes in autism spectrum disorder (ASD).", "results_summary": "The study found associations between ASD and circadian dysregulation, elevated inflammatory cytokines, sleep disorders, and reduced melatonin levels, proposing melatonin or analogs as a potential therapeutic to improve these conditions.", "population_specificity": "Individuals with autism spectrum disorder (ASD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:29.221400+00:00"}
{"study_id": 80522, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of melatonin pathways in the pathophysiology of autism spectrum disorder (ASD), particularly in relation to mitochondrial functioning.", "results_summary": "The study found that decreases in melatonergic pathways are linked to mitochondrial dysfunction in ASD, suggesting a potential role for melatonin in modulating ASD-related biological processes. However, no direct efficacy data on melatonin supplementation were provided.", "population_specificity": "Individuals with autism spectrum disorder (ASD), with a focus on prenatal and postnatal biological processes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:29.743392+00:00"}
{"study_id": 80524, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the direction and magnitude of melatonin supplementation's effect on inflammatory biomarkers.", "results_summary": "Melatonin supplementation significantly decreased TNF-\u03b1 and IL-6 levels, indicating it could be effective in ameliorating inflammatory mediators. The meta-analysis included 13 studies with 749 participants.", "population_specificity": "Not specified (general population inferred from meta-analysis inclusion).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:31.505677+00:00"}
{"study_id": 80516, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore melatonin's potential as an anti-inflammatory adjuvant therapy for nonmotor symptoms in Parkinson's disease.", "results_summary": "The abstract suggests melatonin has been investigated for its anti-inflammatory properties and potential benefits on nonmotor symptoms of Parkinson's disease, though specific results are not detailed.", "population_specificity": "Patients with Parkinson's disease, particularly those experiencing nonmotor symptoms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:33.858679+00:00"}
{"study_id": 80526, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of multidisciplinary rehabilitation, including melatonin measurements, on circadian rhythm and habitual sleep in individuals with preclinical Huntington's disease.", "results_summary": "Both the intervention and control groups exhibited decreases in melatonin concentrations, with no observed changes in sleep or mood outcomes, suggesting the rehabilitation did not impact circadian rhythm.", "population_specificity": "Individuals with preclinical Huntington's disease (premanifest and prodromal stages).", "effective_dosage": "Not specified", "study_duration": "Nine months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:36.205784+00:00"}
{"study_id": 80529, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate melatonin's potential as an adjuvant therapy for colorectal cancer (CRC) by examining its physiological functions and anticarcinogenic effects.", "results_summary": "Melatonin was found to suppress CRC development and progression by activating apoptosis and colon cancer immunity while reducing proliferation, autophagy, metastasis, and angiogenesis. The study highlights melatonin's potential as a beneficial adjuvant therapy for CRC patients.", "population_specificity": "Patients suffering from colorectal cancer (CRC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:36.856390+00:00"}
{"study_id": 80530, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review melatonin's mechanisms in regulating immune responses against cancer cells and its potential as an adjuvant in cancer therapy.", "results_summary": "Melatonin enhances anti-cancer immune cell activity (NK cells, CTLs) and suppresses immune escape facilitators (Tregs, CAFs). It also impacts mitochondrial function, potentially altering immune responses against cancer.", "population_specificity": "Not specified (review of mechanisms, not a clinical study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:38.134906+00:00"}
{"study_id": 80527, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of a melatonin-based nutritional supplement on intraocular pressure (IOP) in normotensive subjects.", "results_summary": "The study found that the melatonin supplement significantly reduced IOP in normotensive subjects after 2 hours of intake, with daily intake showing consistent reductions over 3 days. The acute group also showed a statistically significant reduction in IOP 2-3 hours after intake.", "population_specificity": "Normotensive subjects (67 participants, divided into daily and acute intake groups).", "effective_dosage": "Not specified in the abstract.", "study_duration": "3 days for the daily group; single intake for the acute group.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:38.158495+00:00"}
{"study_id": 80525, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of prolonged-release melatonin (4 mg) for reducing REM-sleep behavior disorder symptoms in Parkinson's disease patients.", "results_summary": "The study found no significant difference in RBD incidents between the melatonin and placebo groups (3.4 vs. 3.6 events/week). Adverse events were mild and similar in both groups.", "population_specificity": "30 Parkinson's disease patients with REM-sleep behavior disorder.", "effective_dosage": "4 mg orally once daily before bedtime.", "study_duration": "8 weeks of intervention.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:38.170980+00:00"}
{"study_id": 80532, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine whether perioperative melatonin reduces the incidence of delirium in older adults undergoing surgical procedures.", "results_summary": "The meta-analysis found that melatonin significantly reduced the incidence of delirium in older surgical patients, with an odds ratio of 0.63 (95% CI 0.46 to 0.87). The incidence of delirium was lower in the melatonin groups (0-30%) compared to comparator groups (4-33%).", "population_specificity": "Older adults (mean age \u2265 50 years) undergoing surgical procedures, including cardiothoracic, orthopedic, or hepatic surgeries.", "effective_dosage": "2 to 8 milligrams daily, administered around the time of surgery.", "study_duration": "1 to 9 days, starting on the evening before or the day of surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:41.580665+00:00"}
{"study_id": 80533, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess whether adding magnesium sulfate (MgSO4) to melatonin therapy could further reduce brain injury markers (S100-B) in infants with hypoxic-ischemic encephalopathy (HIE).", "results_summary": "Infants receiving both MgSO4 and melatonin showed significantly lower S100-B levels at days 2 and 6 compared to those receiving melatonin alone, suggesting MgSO4 may enhance melatonin's neuroprotective effects. Melatonin alone also reduced S100-B by day 6, but the effect was less pronounced than the combination therapy.", "population_specificity": "Neonates with moderate HIE (Sarnat grade II).", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:43.173093+00:00"}
{"study_id": 80535, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review melatonin's role in skin protection and its potential therapeutic benefits when applied topically.", "results_summary": "The study highlights melatonin's importance in skin maintenance and protection against external damage, emphasizing its endogenous production and the benefits of topical application. It also discusses new metabolic pathways involved in melatonin's protective functions in dermal cells.", "population_specificity": "Human skin (general, no specific demographic mentioned)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:44.476253+00:00"}
{"study_id": 80534, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of melatonin supplementation on mental health, glycemic control, cardiometabolic risk markers, and oxidative stress in diabetic hemodialysis patients.", "results_summary": "Melatonin significantly improved sleep quality, reduced depression and anxiety, enhanced glycemic control, lowered inflammatory markers, and improved oxidative stress parameters compared to placebo.", "population_specificity": "Diabetic hemodialysis patients aged 18-80 years.", "effective_dosage": "2 x 5mg/day (10mg total daily dose), taken 1 hour before bedtime.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:44.486431+00:00"}
{"study_id": 80538, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine if melatonin could prevent the development of depression in patients following acute coronary syndrome (ACS).", "results_summary": "Melatonin showed no significant prophylactic antidepressant effect compared to placebo, with no intergroup differences in depressive episodes, dropouts, or adverse events. A general reduction in depressive symptoms occurred in both groups.", "population_specificity": "Adults free of depression at baseline, enrolled within 4 weeks after ACS.", "effective_dosage": "25 mg administered 1 hour before bedtime.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:45.797647+00:00"}
{"study_id": 80536, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers sought to determine if melatonin reduces the incidence of delirium in adults undergoing major cardiac surgery.", "results_summary": "Melatonin did not significantly reduce the incidence, duration, or severity of delirium compared to placebo, with similar rates observed in both groups. No clinically meaningful differences were found in secondary outcomes like hospital stay, cognitive function, or mood symptoms.", "population_specificity": "Adults aged 50+ undergoing coronary artery bypass grafting or valve replacement surgery.", "effective_dosage": "3 mg at night", "study_duration": "7 days (starting 2 days before surgery)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:46.409383+00:00"}
{"study_id": 80539, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of melatonin on ovarian vascular indices during ovarian stimulation for in vitro fertilisation (IVF).", "results_summary": "Melatonin did not change ovarian vascular indices during ovarian stimulation, and these indices did not correlate with oocyte or embryo quality or quantity in IVF cycles. No differences were observed between placebo and any melatonin dose in measured parameters.", "population_specificity": "69 women (mean age 35.8 \u00b1 4.3 years) undergoing their first IVF cycle.", "effective_dosage": "2, 4, or 8 mg, twice a day.", "study_duration": "Days 6-10 of ovarian stimulation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:46.918135+00:00"}
{"study_id": 80541, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of melatonin in migraine pathophysiology and its potential therapeutic implications.", "results_summary": "The study linked decreased melatonin availability to heightened glutamatergic excitatory transmission in migraine and proposed melatonin as a potential treatment alongside sodium butyrate.", "population_specificity": "Not specified (theoretical framework based on existing data).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:50.195658+00:00"}
{"study_id": 80540, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of melatonin in improving primary insomnia in menopausal women.", "results_summary": "The abstract suggests melatonin is a viable option for treating primary insomnia in menopausal women, alongside cognitive behavioral therapy and non-benzodiazepine hypnotics. However, no specific data on melatonin's efficacy or outcomes are provided.", "population_specificity": "Menopausal women with primary insomnia.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:50.458332+00:00"}
{"study_id": 80543, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to review the current evidence for oral medications, including melatonin, used in the treatment of central serous chorioretinopathy (CSCR).", "results_summary": "The study found no robust evidence of efficacy for melatonin in treating CSCR, though it was included among the oral agents reviewed. The mineralocorticoid receptor antagonists, particularly eplerenone, showed the highest quality evidence for efficacy.", "population_specificity": "Patients with central serous chorioretinopathy (CSCR), primarily in the working-age population.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:52.853982+00:00"}
{"study_id": 80542, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential bidirectional relationship between Alzheimer's disease (AD) and sleep disturbances, including the role of alterations in melatonin levels.", "results_summary": "The abstract suggests that melatonin levels are altered in AD and sleep disturbances, potentially contributing to the disease's pathogenesis and progression, but does not provide specific efficacy data on melatonin supplementation.", "population_specificity": "Alzheimer's disease patients with sleep-wake cycle disturbances.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:53.536169+00:00"}
{"study_id": 80546, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Night Time Recharge (NTR), a sleep aid containing cherry extract, improves sleep parameters in young, active adults with mildly poor sleep.", "results_summary": "NTR increased urinary 6-SMT levels (a melatonin marker) compared to placebo, but no detectable melatonin was found in the supplement. Sleep improvements were likely due to tryptophan content, contrasting previous cherry juice studies.", "population_specificity": "Young, active adults with mildly poor sleep (20 participants, 9 female).", "effective_dosage": "Not specified", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:54.364629+00:00"}
{"study_id": 80545, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy and safety of oral melatonin versus oral diazepam in preventing recurrent simple febrile seizures in children.", "results_summary": "Melatonin reduced febrile seizure recurrence to 17%, compared to 37% with diazepam, though the difference was not statistically significant. Adverse effects were less frequent with melatonin (13.3%) than diazepam (23.3%), with no serious side effects reported for melatonin.", "population_specificity": "Children aged six to 50 months with recurrent simple febrile seizures.", "effective_dosage": "0.3 mg/kg every 8 hours.", "study_duration": "Administered during febrile illness for 48 to 72 hours, with follow-up for six months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:55.258608+00:00"}
{"study_id": 80548, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to understand the timing and synchronization of hematopoietic stem and progenitor cells (HSPCs) in bone marrow, particularly in relation to daily light onset and norepinephrine-induced CXCL12 downregulation.", "results_summary": "The abstract does not mention Melatonin or its effects, focusing instead on HSPCs, light onset, and norepinephrine-induced CXCL12 downregulation.", "population_specificity": "Not specified (study focuses on hematopoietic stem and progenitor cells in bone marrow).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:58.001434+00:00"}
{"study_id": 80549, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate melatonin's cardioprotective therapeutic role, assess its development stages, and predict cardiovascular targets using machine learning.", "results_summary": "Preclinical and early clinical studies (phase 2a) suggest cardioprotective benefits of melatonin in heart diseases, but larger phase 3 trials are needed for confirmation. Machine learning identified potential cardiovascular targets for melatonin, but selective agonists like Tasimelteon and Ramelteon have not yet been investigated for cardioprotection.", "population_specificity": "Not specified (review of clinical trials and preclinical studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:58.973082+00:00"}
{"study_id": 80550, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of circadian rhythm disruptions, including melatonin secretion, in depression and how these disturbances might contribute to mood disorders.", "results_summary": "The abstract discusses that disruptions in daily rhythms, including melatonin secretion, are observed in depression and may serve as biomarkers for the disorder. It suggests that treating circadian disturbances could improve mood, but specific results on melatonin's effects are not detailed.", "population_specificity": "Humans and rodents (animal models of depression)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:00.631727+00:00"}
{"study_id": 80552, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the relationship between sleep and pain, including the role of melatonin and other endogenous substances in this interaction.", "results_summary": "The abstract does not provide specific findings about melatonin's effects, only mentioning its potential role in the sleep-pain relationship alongside other substances.", "population_specificity": "Adult and pediatric populations with sleep disturbances and chronic pain.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:01.481749+00:00"}
{"study_id": 80551, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the effect of a single preoperative dose of oral melatonin on postoperative analgesia in patients undergoing major abdominal surgery.", "results_summary": "The study found that preoperative oral administration of 6 mg melatonin significantly reduced pain scores, total morphine consumption, supplemental analgesic requirement, and the incidence of nausea and vomiting compared to placebo. No significant differences were observed between melatonin and vitamin C groups in pain scores or morphine consumption.", "population_specificity": "165 adult patients undergoing elective major abdominal surgery under general anesthesia.", "effective_dosage": "6 mg melatonin, single dose administered one hour before surgery.", "study_duration": "Single dose, effects monitored for 24 hours post-surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:02.215487+00:00"}
{"study_id": 80553, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the anticancer mechanisms of Melatonin, including its effects on apoptosis, angiogenesis, and metastasis, as well as its potential as an adjuvant in chemotherapy.", "results_summary": "The study found that Melatonin exhibits significant anticancer properties, including apoptotic, angiogenic, oncostatic, and anti-proliferative effects on various cancer cells, and may enhance therapeutic outcomes when used alongside chemotherapeutic drugs.", "population_specificity": "Various oncological cells (in vitro or in vivo, not specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:03.517901+00:00"}
{"study_id": 80547, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the role of melatonin in liver damage and biliary functions, exploring its potential therapeutic applications in human biliary diseases.", "results_summary": "The study highlights melatonin's beneficial effects in models of liver damage and suggests its potential use in treating human biliary tree diseases, based on experimental and clinical data.", "population_specificity": "Not specified (general review of experimental and clinical data)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:05.356723+00:00"}
{"study_id": 80554, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential effects of melatonin as an auxiliary treatment in patients with primary sepsis, focusing on anti-inflammatory and oxidative stress reduction outcomes.", "results_summary": "The abstract describes the study protocol but does not report results, as it is a trial design paper. The study will assess outcomes such as APACHE II Score, SOFA score, and inflammatory factors.", "population_specificity": "Patients with primary sepsis at Imamreza hospital.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:06.188154+00:00"}
{"study_id": 80555, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of variations in the N-acetylserotonin (NAS)/melatonin ratio within mitochondria in driving the biological underpinnings of left ventricular hypertrophy (LVH).", "results_summary": "The study proposed that heightened levels of mitochondrial CYP1B1 convert melatonin to NAS, disrupting melatonin and sirtuin-3 interactions, which may contribute to LVH. The gut microbiome and its metabolites, like butyrate, were suggested as modulators of melatonergic pathways and LVH.", "population_specificity": "Not specified (theoretical/model-based study).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:09.009068+00:00"}
{"study_id": 80556, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin's potential as a co-adjuvant treatment in intestinal diseases by examining its interactions with gut microbiota, immune modulation, and inflammatory pathways.", "results_summary": "The study found that melatonin influences gut microbiota and inflammation through diverse metabolites, modulates immune cell activity, exerts antimicrobial effects, and regulates intestinal immune function via NF-\u03baB and STAT1 pathways. It also mediates bacterial activity signals affecting body rhythm and mucosal epithelium oscillation.", "population_specificity": "Not specified (mechanistic focus, likely preclinical or in vitro studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:09.684213+00:00"}
{"study_id": 80557, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of melatonin in improving nerve healing and reducing postoperative pain and numbness following orthognathic surgery.", "results_summary": "Melatonin significantly reduced subjective pain by 50% in early postoperative days and numbness by 30% at 1 week, increasing to over 80% by 3 months. It also improved objective neurosensory function and antioxidant enzyme levels while reducing hydrogen peroxide concentration.", "population_specificity": "Thirty randomly allocated orthognathic surgery patients.", "effective_dosage": "Not specified", "study_duration": "21 consecutive days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:09.729707+00:00"}
{"study_id": 80559, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to explore the effects of a six-week moderate-intensity aerobic exercise intervention on sleep-related biomarkers, including melatonin, in people with multiple sclerosis (MS).", "results_summary": "The study did not report significant changes in melatonin levels due to the exercise intervention, though serotonin levels increased significantly in the aerobic exercise group. The improvement in serotonin correlated with better sleep quality scores.", "population_specificity": "People with multiple sclerosis (MS)", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:11.086249+00:00"}
{"study_id": 80558, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if oral melatonin supplementation after nonsurgical periodontal therapy (NSPT) improved periodontal healing compared to NSPT alone in patients with untreated severe periodontitis.", "results_summary": "Melatonin supplementation resulted in significantly greater mean probing depth (PD) reduction at 6 months for sites with 4-5 mm and >5 mm PD compared to placebo, though no differences were found in FMBS and FMPS. Both treatments were effective in reducing PD overall, but melatonin showed superior outcomes in deeper periodontal sites.", "population_specificity": "Patients with untreated stage III periodontitis.", "effective_dosage": "1 mg per day.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:11.274952+00:00"}
{"study_id": 80560, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the impact of melatonin on Parkinson's disease (PD) by reviewing preclinical and clinical studies, focusing on its effects on molecular mechanisms and clinical symptoms.", "results_summary": "Melatonin supplementation was found to inhibit pathways related to apoptosis, autophagy, oxidative stress, inflammation, \u03b1-synuclein aggregation, and dopamine loss in PD. It also improved some nonmotor symptoms in PD patients, though limited studies have evaluated its role in molecular mechanisms and clinical symptoms.", "population_specificity": "Patients with Parkinson's disease (PD) and preclinical models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:13.595413+00:00"}
{"study_id": 80564, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of melatonin in headache disorders, including its effects on trigeminal activation and CGRP regulation.", "results_summary": "Melatonin was found to decrease trigeminal activation in headache animal models and regulate CGRP release. It has been successfully used to treat migraine, cluster headaches, and other headache disorders.", "population_specificity": "Primary and secondary headache disorder patients (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:16.213267+00:00"}
{"study_id": 80563, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the pharmacokinetic and safety profiles of a novel continuous release and absorption melatonin (CRA-melatonin) with an immediate-release melatonin (IR-melatonin) in healthy adults.", "results_summary": "CRA-melatonin maintained plasma melatonin levels above the targeted threshold for a median of 6.7 hours compared to 3.7 hours for IR-melatonin, with no adverse events reported for CRA-melatonin and five for IR-melatonin. The study concluded that CRA-melatonin offers a significant advancement in melatonin delivery.", "population_specificity": "Healthy adult volunteers", "effective_dosage": "5 mg single dose", "study_duration": "Single-dose, 2-way crossover trial (conducted over approximately one month)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:16.747102+00:00"}
{"study_id": 80565, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to summarize existing data on melatonin's hypolipidemic effects and explore its potential as a cardioprotective agent by modulating cholesterol metabolism and reducing oxidative stress.", "results_summary": "The abstract suggests melatonin may reduce cardiovascular risk by influencing cholesterol metabolism and minimizing oxidative damage, but highlights inconsistencies between clinical observations and molecular mechanisms.", "population_specificity": "Not specified (review of available data)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:17.508634+00:00"}
{"study_id": 80566, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether 25 mg melatonin administered for twelve weeks could improve endothelial dysfunction (ED) in patients following acute coronary syndrome (ACS).", "results_summary": "Melatonin treatment did not improve ED and may have worsened it, with the placebo group showing better outcomes. No significant differences were found in biomarker concentrations (l-arginine, asymmetric dimethylarginine, uric acid).", "population_specificity": "31 patients with acute coronary syndrome (ACS).", "effective_dosage": "25 mg melatonin.", "study_duration": "Twelve weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:17.737349+00:00"}
{"study_id": 80568, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin's role in regulating immune responses, particularly its effects on T-cell differentiation and inflammatory pathways in autoimmune diseases.", "results_summary": "Melatonin modulates T-cell subsets, promotes regulatory T-cell differentiation, suppresses Th17 cells, reduces inflammatory cytokines, and mitigates oxidative stress and apoptosis, suggesting therapeutic potential for autoimmune diseases.", "population_specificity": "Not specified (review of existing research on autoimmune disease mechanisms).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:19.002135+00:00"}
{"study_id": 80567, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine melatonin's role in regulating adipocyte development and function, particularly its effects on white, beige, and brown adipocytes, and its potential as a therapeutic agent for obesity and metabolic disorders.", "results_summary": "Melatonin was found to influence adipogenesis, promote beige formation and white adipose tissue browning, enhance brown adipose tissue activity, improve anti-inflammatory and antioxidative effects, regulate adipokine secretion, and prevent weight gain, suggesting its potential in managing obesity and metabolic diseases.", "population_specificity": "Not specified (general mammalian adipocyte focus)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:19.777084+00:00"}
{"study_id": 80570, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of melatonin in the pathoetiology and pathophysiology of endometriosis, particularly its association with mitochondrial function and metabolic alterations.", "results_summary": "The study suggests that alterations in the N-acetylserotonin/melatonin ratio may play a key role in endometriosis development, implicating melatonin in mitochondrial dysfunction and systemic metabolic changes. These findings highlight potential treatment implications for endometriosis and its association with cancers.", "population_specificity": "Women with endometriosis (systemic focus, not limited to a specific demographic).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:22.681892+00:00"}
{"study_id": 80572, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specifically address Melatonin; it focuses on the need for neuroprotective strategies in preterm infants and mentions magnesium sulfate and caffeine.", "results_summary": "The abstract does not report any findings related to Melatonin.", "population_specificity": "Preterm infants", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:23.088383+00:00"}
{"study_id": 80571, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential synergistic role of melatonin with Thymosin Beta-4 (T\u03b24) in tissue repair, particularly in cardiac healing.", "results_summary": "The study suggests that melatonin may work in association/synergism with T\u03b24 and other factors to promote tissue repair, including cardiac muscle and skeletal muscle. However, specific outcomes related to melatonin alone are not detailed.", "population_specificity": "Not specified (general tissue repair context, including cardiac and skeletal muscle).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:24.722155+00:00"}
{"study_id": 80575, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to summarize available data on the potential risks and benefits of melatonin and other non-pharmacologic remedies for esophageal symptoms.", "results_summary": "The abstract does not provide specific findings about melatonin's effects, only mentioning it as one of several remedies under investigation for esophageal symptoms.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:25.056126+00:00"}
{"study_id": 80574, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of melatonin in entraining circadian rhythms and treating circadian rhythm sleep-wake disorders (CRSWDs).", "results_summary": "The study highlights melatonin's role in synchronizing the circadian clock with environmental cues and its therapeutic use in CRSWDs, alongside light therapy and sleep hygiene.", "population_specificity": "Patients with circadian rhythm sleep-wake disorders (CRSWDs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:25.373460+00:00"}
{"study_id": 80573, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to propose that melatonergic pathway regulation within mitochondria provides an integrative framework for understanding breast cancer pathophysiology.", "results_summary": "The study suggests melatonin is toxic to breast cancer cells, and breast cancer cells may adapt to reduce mitochondrial melatonin synthesis. The aryl hydrocarbon receptor's role in breast cancer may involve converting melatonin to N-acetylserotonin (NAS), which activates TrkB receptor, promoting cancer cell survival and migration.", "population_specificity": "Breast cancer cells (in vitro or theoretical model, not specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:25.967259+00:00"}
{"study_id": 80577, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of melatonin on the incidence of delirium in hospitalized patients.", "results_summary": "Melatonin did not significantly reduce delirium incidence but was associated with shorter ICU stays. No differences were found in the need for physical restraints or sedative agents.", "population_specificity": "Hospitalized patients, including those in intensive care units.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:26.357999+00:00"}
{"study_id": 80576, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore how the Nrf2 signaling pathway explains some of the therapeutic and biological effects of melatonin, particularly its antioxidant and anti-inflammatory properties.", "results_summary": "The study found that melatonin exhibits multiple beneficial biological and therapeutic activities, including antioxidant, anti-inflammatory, anti-tumor, anti-diabetic, and cardioprotective effects, mediated in part by the Nrf2 signaling pathway.", "population_specificity": "Not specified (general review of existing literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:27.285652+00:00"}
{"study_id": 80579, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the known significance of melatonin in colorectal cancer and explore its potential clinical use.", "results_summary": "Melatonin modulates signaling pathways involved in cancer progression, regulates immune function and tumor microenvironment, and acts as an antioxidant. It shows beneficial effects in colorectal cancer, including apoptosis induction, increased sensitivity to chemotherapy and radiotherapy, and inhibition of proliferation, migration, and invasion.", "population_specificity": "Colorectal cancer patients (no specific demographic details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:30.406061+00:00"}
{"study_id": 80578, "supplement_id": 1328, "safety_score": "75", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the therapeutic and preventative potential of melatonin supplementation in gynecology, focusing on its effects on fertility, oocyte quality, and gestational outcomes.", "results_summary": "Melatonin supplementation (2-18 mg daily) showed potential to improve fertility rate, oocyte quality, and embryo maturation in short-term studies (up to six months), but evidence on gestational outcomes remains scarce.", "population_specificity": "Women and animal models in gynecological studies.", "effective_dosage": "2-18 mg daily", "study_duration": "Up to six months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:30.493300+00:00"}
{"study_id": 80582, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers reviewed treatment options for delayed and advanced sleep-wake phase disorders, including melatonin administration.", "results_summary": "The abstract mentions melatonin as a treatment option for sleep-wake phase disorders but does not provide specific efficacy data. Future directions are discussed, but no detailed results are given.", "population_specificity": "Individuals with delayed or advanced sleep-wake phase disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:32.261870+00:00"}
{"study_id": 80581, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of melatonin in treating Non-24-hour sleep-wake rhythm disorder, particularly in blind and sighted individuals.", "results_summary": "Melatonin was found effective in treating Non-24-hour sleep-wake rhythm disorder in blind individuals, while sighted individuals required additional time cues like light, social interactions, and activity for effective treatment.", "population_specificity": "Blind individuals without light perception and sighted individuals with Non-24-hour sleep-wake rhythm disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:33.073991+00:00"}
{"study_id": 80580, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of melatonin on sleep quality, sedation, anxiolysis, opioid consumption, and extubation time in patients undergoing surgical treatment for zygomatic fractures.", "results_summary": "Melatonin improved sleep quality the night before surgery and reduced intraoperative opioid consumption but did not enhance anxiolysis. It also increased the time required for safe endotracheal extubation compared to placebo.", "population_specificity": "Patients undergoing surgical treatment for zygomatic fractures.", "effective_dosage": "10 mg (one tablet the night before surgery and another 2 hours before surgery).", "study_duration": "Short-term (preoperative period).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:33.357626+00:00"}
{"study_id": 80583, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine how the human circadian pacemaker responds to fragmented light exposure and its potential to influence melatonin rhythms.", "results_summary": "The study found that ultra-short durations of light (1-2 seconds total) distributed as 2-millisecond pulses could elicit circadian pacemaker responses comparable to continuous hour-long light exposure, optimizing phase-shifting effects on melatonin rhythms.", "population_specificity": "Not specified (laboratory setting, likely healthy adults)", "effective_dosage": "Not specified (light exposure details: 2-millisecond pulses distributed over an hour)", "study_duration": "Not specified (laboratory recordings over several hundred days)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:34.666072+00:00"}
{"study_id": 80585, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the patient-perceived effectiveness of melatonin versus zolpidem for managing hospital-related insomnia.", "results_summary": "Melatonin showed higher estimated adjusted means for total sleep effectiveness (206.8 mm) compared to zolpidem (187.4 mm), suggesting better perceived sleep outcomes in hospitalized patients. The study did not report statistical significance or clinical relevance details.", "population_specificity": "Hospitalized inpatients without acute psychological issues or substance abuse history.", "effective_dosage": "Not specified", "study_duration": "Single-night administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:36.115370+00:00"}
{"study_id": 80584, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the clinical applications of exogenous melatonin in psychiatric disorders, focusing on its chronobiotic and sleep-inducing effects.", "results_summary": "Exogenous melatonin was found useful for preventing relapse in stabilized psychiatric patients with insomnia or poor sleep quality and as an adjuvant treatment during acute phases of mood disorders, ADHD, peri-surgical anxiety, and schizophrenia. It also showed potential for treating painful symptoms in somatoform disorders like fibromyalgia and irritable bowel syndrome.", "population_specificity": "Adults with psychiatric disorders (bipolar disorder, major depressive disorder, seasonal affective disorder, ADHD, schizophrenia) and somatoform disorders (fibromyalgia, irritable bowel syndrome, etc.).", "effective_dosage": "0.125mg (small dose mentioned for chronobiotic action; dose-effect relationship noted for sleep-inducing effects).", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:36.173820+00:00"}
{"study_id": 80586, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the effect of melatonin supplementation on dyslipidemia and anthropometric indices through a systematic review and meta-analysis.", "results_summary": "Melatonin supplementation improved LDL-C and triglyceride levels but had no significant effect on HDL-C or anthropometric indices. The findings suggest melatonin may be beneficial for lipid parameters in cardiovascular disease prevention.", "population_specificity": "641 participants across 12 trials (specific demographics not detailed).", "effective_dosage": "0.8-30 mg (frequency not specified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:38.151869+00:00"}
{"study_id": 80587, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether antenatal maternal melatonin supplementation could improve neurodevelopment in children at 2 years of age following severe, early-onset fetal growth restriction (FGR).", "results_summary": "The study presents a protocol for a randomized, placebo-controlled trial, so no results on melatonin's effects are yet available. The primary outcome will measure cognitive differences using the Bayley-III scale.", "population_specificity": "Pregnant women (n=336) with singleton pregnancies complicated by FGR between 23+0 and 31+6 weeks gestation.", "effective_dosage": "30 mg melatonin per day", "study_duration": "Continued until birth", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:38.991017+00:00"}
{"study_id": 80590, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the neurobiological mechanisms involved in the modulation of pain by sleep deficiency, including the role of melatonin.", "results_summary": "The abstract does not provide specific findings about melatonin's effects, only mentioning it as one of the systems involved in pain modulation due to sleep deficiency.", "population_specificity": "Not specified (review paper)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:40.726416+00:00"}
{"study_id": 80588, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to assess whether a core outcome set is needed for studies evaluating interventions, including Melatonin, for non-respiratory sleep disturbances in children with neurodisabilities.", "results_summary": "Eleven Melatonin studies (85%) recorded adverse events, but there was variation in data collection and reporting. The study found inconsistency in outcome measures used across studies, suggesting a need for standardized core outcome sets.", "population_specificity": "Children (\u226418 years old) with neurodisabilities experiencing non-respiratory sleep disturbances.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:41.961272+00:00"}
{"study_id": 80589, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin's neuroprotective mechanisms in Alzheimer's disease (AD), focusing on its role in attenuating circadian disruption, A\u03b2 accumulation, and tau hyperphosphorylation.", "results_summary": "Melatonin was found to inhibit circadian disruption by regulating clock genes, reduce A\u03b2 accumulation and tau hyperphosphorylation via GSK3 and CDK5 pathways, and exhibit neuroprotective effects by blocking A\u03b2 production, oligomerization, oxidative stress, and neuronal death in AD progression.", "population_specificity": "Not specified (general focus on Alzheimer's disease pathology)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:42.567717+00:00"}
{"study_id": 80591, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin's physiological effects, including its immediate, prospective, chronobiotic, and transgenerational actions, and its role in metabolism and metabolic disorders.", "results_summary": "The study highlights melatonin's multifaceted roles in regulating metabolism, including circadian and seasonal effects, and its importance in fetal programming for balanced energy metabolism in adulthood. It emphasizes the need for a broader understanding of melatonin's actions beyond classical endocrinology to interpret its role in health maintenance.", "population_specificity": "Mammals (general, with implications for humans)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:43.359013+00:00"}
{"study_id": 80592, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were examining the potential protective effects of Nrf2 pathway activators, including Melatonin, against mechanisms contributing to poor outcomes following subarachnoid hemorrhage (SAH).", "results_summary": "The abstract does not provide specific results regarding Melatonin's effects, only mentioning that Nrf2 pathway activators like sulforaphane, curcumin, astaxanthin, and lycopene have potential protective effects against SAH-related mechanisms.", "population_specificity": "Not specified (abstract focuses on general mechanisms of SAH).", "effective_dosage": "Not provided", "study_duration": "Not provided", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:44.869483+00:00"}
{"study_id": 80593, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to review the literature on primary stabbing headache (PSH) and assess treatment options, including melatonin.", "results_summary": "The abstract mentions melatonin as a potential treatment option for PSH, but no specific efficacy data or outcomes are provided. Further studies are required to validate its effectiveness.", "population_specificity": "Patients with primary stabbing headache, including those with co-morbidities like migraine.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:45.469571+00:00"}
{"study_id": 80595, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review melatonin's potential role in modulating heart failure and cardiac cachexia via neurohormonal regulation and its possible mechanisms of action.", "results_summary": "Melatonin likely regulates signaling pathways related to muscle wasting in cardiac cachexia by reducing tumor necrosis factor \u03b1 levels, activating insulin-like growth factor-1 gene expression, inhibiting proteolytic pathways (NF-\u03baB, renin-angiotensin system, forkhead box protein O1), and increasing protein synthesis via Akt and mTOR activation. More cellular and clinical studies are needed to confirm these mechanisms.", "population_specificity": "Patients with heart failure and cardiac cachexia (not specified further).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:48.527173+00:00"}
{"study_id": 80596, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review melatonin's anticancer effects on colorectal cancer (CRC), including its mechanisms of action and potential for combination therapy.", "results_summary": "The study found melatonin exhibits anticancer effects on CRC through various mechanisms, including gene regulation, cell proliferation control, apoptosis, autophagy, antiangiogenesis, and immunomodulation. It also suggests melatonin's usefulness in combination therapy with other anticancer drugs.", "population_specificity": "Not specified (review of existing literature on CRC and melatonin)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:48.868807+00:00"}
{"study_id": 80598, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize melatonin's anticervical cancer effects and its underlying molecular mechanisms as an adjuvant therapy.", "results_summary": "The study found that melatonin exhibits inhibitory effects on cervical cancer by targeting various molecular mechanisms, suggesting its potential as an adjuvant therapy to reduce side effects and toxicities of current treatments. Experimental evidence supports its wide-range anticancer activities.", "population_specificity": "Cervical cancer patients (specific demographic details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:49.496884+00:00"}
{"study_id": 80597, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether melatonin could improve the response to erythropoietin (EPO) in anemic patients with chronic kidney disease (CKD) by reducing inflammation.", "results_summary": "Melatonin significantly increased hemoglobin levels, serum iron, and transferrin saturation ratio while reducing inflammatory markers (TNF-\u03b1, IL-1\u03b2, IL-6) compared to baseline and the control group.", "population_specificity": "41 CKD patients with hemoglobin levels less than 11g/dl.", "effective_dosage": "5mg melatonin.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:50.113897+00:00"}
{"study_id": 80599, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of melatonin and temazepam versus placebo on sleep quality in hospitalized older patients with sleeping problems.", "results_summary": "The abstract does not provide results, as the study is described as \"Pre-results.\"", "population_specificity": "Hospitalized patients aged 60 years and older with new or aggravated sleeping problems.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:50.801147+00:00"}
{"study_id": 80600, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To investigate the efficacy of exogenous melatonin and melatonin receptor agonists in improving delirium, sleep, and other clinical outcomes in ICU patients.", "results_summary": "Melatonin and its agonists were associated with improved sleep duration, reduced awakenings, lower delirium prevalence, and shorter ICU stays. The effects on sleep duration showed a trend but were not statistically significant, while other outcomes were significant.", "population_specificity": "Adult subjects admitted to the intensive care unit (ICU).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:52.852472+00:00"}
{"study_id": 80601, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the efficacy and safety of prolonged-release melatonin mini-tablets (PedPRM) in improving sleep duration and onset in children with Autism Spectrum Disorder or Smith-Magenis syndrome and insomnia, as well as its effects on child behavior and caregiver quality of life.", "results_summary": "PedPRM significantly improved externalizing behavior (but not internalizing behavior) and caregivers' quality of life compared to placebo, with clinically relevant improvements in 53.7% of treated subjects versus 27.6% in the placebo group. The treatment also alleviated insomnia-related difficulties in children.", "population_specificity": "Children aged 2-17.5 years with Autism Spectrum Disorder or Smith-Magenis syndrome and insomnia.", "effective_dosage": "2-5 mg (prolonged-release mini-tablets).", "study_duration": "13 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:55.526973+00:00"}
{"study_id": 80602, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review melatonin's role in enhancing apoptosis in cancer cells exposed to radiation and chemotherapy, and its potential to mitigate treatment side effects.", "results_summary": "Melatonin demonstrated protective effects against toxic side effects of radiation and chemotherapy, while also sensitizing some cancer cells to therapy by modulating apoptosis pathways. It influenced key mediators like mitochondria, Bax, Bcl-2, ROS, and apoptosis receptors to facilitate apoptosis.", "population_specificity": "Not specified (review of mechanisms, not a clinical study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:56.673426+00:00"}
{"study_id": 80604, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the roles of melatonin in breast cancer treatment, focusing on its molecular actions and antitumor properties.", "results_summary": "Melatonin exhibits antioxidant, anti-inflammatory, and oncostatic effects, with potential antitumor properties that may suppress breast cancer development in vitro and in animal models through various mechanisms.", "population_specificity": "Not specified (abstract discusses general mechanisms and in vitro/animal models).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:57.025746+00:00"}
{"study_id": 80603, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the neuroprotective effects of melatonin in multiple sclerosis (MS) and its potential mechanisms of action.", "results_summary": "The study suggests melatonin may protect against behavioral deficits and neuropathological characteristics of MS through antioxidant, anti-inflammatory, anti-apoptotic, and anti-demyelinating properties, as well as immune system regulation. Clinical evidence supports its potential benefits in MS patients.", "population_specificity": "Patients with multiple sclerosis (MS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:57.499698+00:00"}
{"study_id": 80605, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate interventions, including melatonin, that could limit oxidative stress associated with hypoxic-ischemic encephalopathy in asphyxiated infants.", "results_summary": "Melatonin was identified as a potential intervention targeting the acute injury phase of hypoxic-ischemic encephalopathy, alongside other treatments like allopurinol and noble gases. The abstract suggests it may help mitigate oxidative stress but does not provide specific efficacy data for melatonin alone.", "population_specificity": "Asphyxiated infants with hypoxic-ischemic encephalopathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:57.861926+00:00"}
{"study_id": 80607, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of melatonin in Alzheimer's disease etiopathogenesis and pathophysiology, focusing on its potential to improve mitochondrial function and reduce oxidative stress.", "results_summary": "The study identified melatonin as one of the key terms in AD research but did not provide specific findings on its effects. The abstract concludes that AD treatment strategies should target mitochondrial dysfunction and oxidative stress, implying melatonin's potential relevance.", "population_specificity": "Both animal and human subjects (not specified further).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:58.571170+00:00"}
{"study_id": 80609, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of monoamines, including melatonin, in Alzheimer's Disease (AD) and explore their potential as therapeutic tools.", "results_summary": "The study highlights melatonin's potential benefits in AD through mechanisms like interaction with G-protein-coupled receptors, regulation of free radicals, and effects on Tau phosphorylation and amyloid-beta accumulation. Recent derivatives show promising pharmacokinetic properties in both murine models and humans.", "population_specificity": "Mammals (murine models and humans)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:00.004714+00:00"}
{"study_id": 80612, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not mention Melatonin or its study.", "results_summary": "The abstract does not discuss Melatonin or its effects.", "population_specificity": "Premature infants and newborns with oxidative stress-related conditions.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:03.045864+00:00"}
{"study_id": 80611, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the anxiolytic effects of oral melatonin and midazolam in patients undergoing third molar surgery and assess their impact on cognitive and psychomotor functions.", "results_summary": "Melatonin significantly reduced anxiety compared to placebo but was less effective than midazolam. It did not significantly affect cognitive or psychomotor functions, unlike midazolam, which impaired these functions.", "population_specificity": "Patients scheduled for impacted third molar surgery.", "effective_dosage": "0.4 mg/kg (single oral dose).", "study_duration": "Single dose, effects measured after 60 minutes.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:04.683860+00:00"}
{"study_id": 80614, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate melatonin's potential as a therapeutic agent for treating childhood cancer, focusing on its safety and efficacy.", "results_summary": "Melatonin demonstrated significant positive effects on adult cancers, improving survival and treatment response rates while slowing disease progression, and appears safe for children.", "population_specificity": "Children with cancer (potential application based on adult studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:04.842140+00:00"}
{"study_id": 80613, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate melatonin's anticancer properties, focusing on its potential role in colorectal cancer (CRC) treatment and prevention, including its effects on tumor growth, metastasis, and alleviation of therapy side effects.", "results_summary": "The study found that melatonin exhibits oncostatic effects across all stages of tumor growth, mitigates malignant progression and metastasis, and improves patient welfare during radio/chemotherapy. Epidemiological, in vitro, in vivo, and clinical evidence supports its broad protective potential against CRC.", "population_specificity": "Colorectal cancer (CRC) patients, particularly those with metastatic CRC.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:05.465811+00:00"}
{"study_id": 80594, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness of nonpharmacological sleep interventions, including melatonin, for improving sleep in hospitalized patients.", "results_summary": "The review found melatonin to be one of the most promising interventions for improving sleep in inpatient settings, though the overall literature was limited in quality and unable to recommend specific interventions. Environmental modifications like quiet time and ear plugs/eye masks were also noted as potentially beneficial.", "population_specificity": "Hospitalized psychiatric and older adult patients from 18 countries.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:05.654488+00:00"}
{"study_id": 80616, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the molecular mechanisms by which melatonin may contribute to the treatment of ovarian cancer.", "results_summary": "The study highlights melatonin's anti-carcinogenic properties, including regulation of estradiol production, apoptosis stimulation, anti-angiogenic effects, and antioxidant activities, suggesting its potential beneficial role in ovarian cancer treatment.", "population_specificity": "Ovarian cancer patients (general, not specific subgroup).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:07.057367+00:00"}
{"study_id": 80615, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "To clinically assess the anti-aging efficacy and safety of a topical 3-in-1 night facial serum combining melatonin, bakuchiol, and ascorbyl tetraisopalmitate in all skin types.", "results_summary": "The serum significantly reduced wrinkles (11%), increased skin firmness (8%), reduced redness (70%), and improved overall skin quality and complexion. It also enhanced hydration and reduced transepidermal water loss, with favorable tolerability across all skin types.", "population_specificity": "103 subjects with various skin types, including oily skin.", "effective_dosage": "Once daily application (specific concentration not detailed).", "study_duration": "12 weeks (3 months) for primary efficacy and safety study; 1 month for oily skin studies.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:07.240654+00:00"}
{"study_id": 80617, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of melatonin as a treatment for tinnitus by examining its effects on neural plasticity, oxidative/nitrosative stress, apoptosis, and autophagy.", "results_summary": "The study suggests melatonin may ameliorate tinnitus by protecting against cochlear damage caused by acoustic trauma and ototoxic agents, and clinical studies indicate it can reduce tinnitus severity.", "population_specificity": "Patients with tinnitus (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:10.889825+00:00"}
{"study_id": 80620, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore melatonin's effects on autophagy and its role in tumorigenesis, focusing on its potential as an anticancer agent.", "results_summary": "The study highlights melatonin's anticancer effects, particularly its ability to interfere with cell signaling pathways and modulate autophagy, which may contribute to preventing or treating malignancies.", "population_specificity": "Not specified (general discussion of mechanisms, not a clinical trial).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:12.476543+00:00"}
{"study_id": 80619, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the impact of melatonin supplementation on systolic and diastolic blood pressure through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "The meta-analysis found significant reductions in both systolic (-3.43 mmHg) and diastolic (-3.33 mmHg) blood pressure after melatonin supplementation compared to control treatment, with robust results and no evidence of publication bias.", "population_specificity": "Not specified (meta-analysis of RCTs)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:12.731831+00:00"}
{"study_id": 80610, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize melatonin's role as a master regulator in molecular pathways, particularly in cell death and inflammation, with a focus on newborn care.", "results_summary": "Melatonin exhibits beneficial effects through receptor-dependent and independent mechanisms, acting as a free radical scavenger and regulating cell death and inflammation, with potential for exogenous administration.", "population_specificity": "Newborn care (contextual focus, not a specific study population)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:12.785181+00:00"}
{"study_id": 80621, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of melatonin supplementation on mental health, metabolic parameters, and genetic markers in women with polycystic ovary syndrome (PCOS).", "results_summary": "Melatonin significantly improved sleep quality, reduced depression and anxiety scores, lowered insulin resistance and cholesterol levels, and upregulated beneficial gene expression related to insulin and lipid metabolism.", "population_specificity": "Women aged 18-40 with PCOS.", "effective_dosage": "10 mg melatonin (two 5 mg capsules) once daily before bedtime.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:13.265932+00:00"}
{"study_id": 80622, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate pineal gland abnormalities and melatonin secretion in schizophrenia patients and review the effects of add-on exogenous melatonin treatment on sleep quality and metabolic symptoms.", "results_summary": "The study found reduced midnight plasma melatonin levels in schizophrenia patients compared to healthy controls, along with structural abnormalities in the pineal gland. Add-on melatonin treatment modestly improved sleep quality, metabolic effects of antipsychotics, and tardive dyskinesia symptoms.", "population_specificity": "Schizophrenia patients compared to healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:14.486979+00:00"}
{"study_id": 80623, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to estimate the risk of acute liver injury (ALI) associated with agomelatine (a melatonin receptor agonist) and other antidepressants compared to citalopram in routine clinical practice.", "results_summary": "The study found that agomelatine was not associated with an increased risk of ALI hospitalization compared to citalopram, with odds ratios consistently below 1 across different endpoints and sensitivity analyses. Most other antidepressants also showed lower risk estimates than citalopram, though further studies are needed for confirmation.", "population_specificity": "New antidepressant users (3,238,495) and agomelatine users (74,440) from Denmark, Germany, Spain, and Sweden (2009-2014).", "effective_dosage": "Not specified", "study_duration": "Study period was 2009-2014, but individual intervention duration not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:17.151973+00:00"}
{"study_id": 80624, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review various treatment modalities, including melatonin, for chronic central serous chorioretinopathy and provide updates based on recent clinical trial results.", "results_summary": "The abstract mentions melatonin as one of the treatment options reviewed, but no specific results or comparative efficacy data for melatonin are provided. Complications are noted as uncommon across treatments, but direct outcomes for melatonin are not detailed.", "population_specificity": "Middle-aged men with chronic central serous chorioretinopathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:18.148303+00:00"}
{"study_id": 80627, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate recent evidence on complementary and integrative medicine, including melatonin, for treating episodic migraine.", "results_summary": "The abstract suggests that new research indicates potential benefit of melatonin for migraine treatment, though methodological challenges in studies limit definitive conclusions.", "population_specificity": "Patients with episodic migraine.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:19.155176+00:00"}
{"study_id": 80628, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the principal properties of melatonin and explore its potential clinical applications for critically ill patients.", "results_summary": "The study found that melatonin improves sleep quality and has analgesic, anxiolytic, antiinflammatory, and antioxidative effects. Clinical studies support its efficacy in these areas.", "population_specificity": "Critically ill patients (implied, but not explicitly specified in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:20.156314+00:00"}
{"study_id": 80625, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of Melatonin in controlling REM sleep behavior disorder (RBD) in patients with dementia with Lewy bodies (DLB).", "results_summary": "The study found that Melatonin is effective in controlling RBD in DLB patients, alongside clonazepam. No adverse effects or comparative efficacy details were provided.", "population_specificity": "Patients with dementia with Lewy bodies (DLB) experiencing REM sleep behavior disorder (RBD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:20.914700+00:00"}
{"study_id": 80626, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether consuming beefsteak tomatoes before bed could increase urinary melatonin levels (aMT6s) and improve sleep quality in obese postmenopausal women.", "results_summary": "The study found that consuming 250 g of beefsteak tomatoes before sleep for 8 weeks significantly increased urinary aMT6s levels (10-fold higher than control) and improved all components of the Pittsburgh Sleep Quality Index (PSQI).", "population_specificity": "Obese postmenopausal women (n=36 completed the trial).", "effective_dosage": "250 g of beefsteak tomatoes 2 hours before sleep daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:21.286894+00:00"}
{"study_id": 80629, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study aimed to provide a comprehensive understanding of Alzheimer's disease etiopathogenesis and pathophysiology using a quintuple framework, but it does not specifically focus on Melatonin.", "results_summary": "The abstract does not mention Melatonin or its effects, as the study focuses on thyroid dysfunction, vitamin D deficiency, sex hormones, mitochondria dysfunction, and oxidative stress in Alzheimer's disease.", "population_specificity": "Elderly individuals at risk for or diagnosed with Alzheimer's disease.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:22.193654+00:00"}
{"study_id": 80630, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to determine whether perioperative melatonin improves postoperative pain control and reduces opioid consumption.", "results_summary": "Melatonin reduced postoperative pain scores by \u226530% and decreased opioid consumption in 3 studies, but 4 studies reported no significant effect on pain.", "population_specificity": "Postoperative patients (n=586 across 9 studies).", "effective_dosage": "Not specified", "study_duration": "Postoperative days 1-2 (specific intervention duration not detailed).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:24.026472+00:00"}
{"study_id": 80618, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to analyze the efficacy and safety of melatonin in treating pediatric insomnia and sleep disturbances, including those associated with neurological conditions.", "results_summary": "Melatonin was found to be safe and effective for treating primary sleep disorders and sleep disturbances linked to neurological conditions, though optimal dosing regimens remain uncertain and require individualization.", "population_specificity": "Children with sleep disturbances, including those with neurological conditions.", "effective_dosage": "Not specified (individualized based on severity and type of disorder).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:24.630859+00:00"}
{"study_id": 80632, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate melatonin's potential in understanding and combating neurodegenerative processes by examining its effects on cognitive enhancement and oxidative signaling.", "results_summary": "Melatonin demonstrated cognitive enhancement and inhibition of oxidative signaling, suggesting its efficacy in mitigating neurodegenerative processes. The review highlighted melatonin's therapeutic potential in regulating pathogenic mechanisms and preventing altered signaling pathways in cellular, animal, and clinical models.", "population_specificity": "Cellular and animal models, along with clinical evaluations pertaining to neurodegeneration (specific human population not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:26.829903+00:00"}
{"study_id": 80635, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore novel targets, including melatonin receptors, for safer and more effective antimigraine drugs.", "results_summary": "Melatonin shows considerable promise as a novel drug for migraine prevention and treatment, but further research is needed to confirm its effectiveness and safety.", "population_specificity": "General migraine population (no specific subgroup mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:27.884710+00:00"}
{"study_id": 80634, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of quetiapine and melatonin on QTc prolongation in critically ill patients with delirium.", "results_summary": "The study found no significant difference in QTc prolongation between the quetiapine and melatonin groups, with melatonin showing a mean change of -0.18 ms, indicating minimal impact on QTc.", "population_specificity": "Critically ill patients with delirium", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:29.081293+00:00"}
{"study_id": 80633, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to assess the pharmacokinetics, safety, and optimal dosage of melatonin in neonates with hypoxic-ischemic encephalopathy (HIE) undergoing hypothermia.", "results_summary": "Melatonin was safely administered at 0.5 mg/kg without adverse effects, achieving a peak plasma concentration of 0.25 \u00b5g/mL. The study found prolonged half-life and clearance in neonates compared to adults, with steady-state estimated after four infusions.", "population_specificity": "Neonates with hypoxic-ischemic encephalopathy (HIE) undergoing hypothermia.", "effective_dosage": "0.5 mg/kg, enteral administration.", "study_duration": "Not specified (blood samples collected at selective times post-infusion).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:29.282663+00:00"}
{"study_id": 80636, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of melatonin in managing rapid eye movement sleep behavior disorder (RBD) in patients with dementia with Lewy bodies (DLB).", "results_summary": "The abstract indicates that melatonin can be used to manage RBD, a common core clinical feature of DLB, alongside clonazepam, but does not provide specific efficacy data or comparative outcomes.", "population_specificity": "Patients with dementia with Lewy bodies (DLB) experiencing rapid eye movement sleep behavior disorder (RBD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:29.935602+00:00"}
{"study_id": 80638, "supplement_id": 1328, "safety_score": "85", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety profile of exogenous melatonin supplementation in humans by conducting a systematic review of clinical evidence.", "results_summary": "The study found that melatonin has a generally favorable safety profile, with most adverse events being minor, short-lived, and manageable. Some studies reported adverse effects related to endocrine and cardiovascular function, influenced by dosage, timing, and interactions with antihypertensive drugs.", "population_specificity": "Humans (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "Potential interactions with antihypertensive drugs.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:32.200166+00:00"}
{"study_id": 80637, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of pharmacologic treatments, including melatonin, for sleep disorders in children and adolescents, particularly those with neurodevelopmental disorders.", "results_summary": "Melatonin significantly improved sleep latency, duration, and wake time after sleep onset, with the greatest benefits observed in children with autism or neurodevelopmental disorders. Adverse events were infrequent with melatonin but more common with other drugs like eszopiclone or zolpidem.", "population_specificity": "Children and adolescents (mean age 8.2 years), including those with neurodevelopmental disorders such as autism and ADHD.", "effective_dosage": "Not specified", "study_duration": "1-13 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:32.262233+00:00"}
{"study_id": 80640, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential effect of melatonin supplementation on blood pressure in patients with metabolic disorders.", "results_summary": "The study conducted a systematic review and meta-analysis of RCTs but did not provide specific findings on melatonin's effects on blood pressure in the abstract.", "population_specificity": "Patients with metabolic disorders.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:34.354488+00:00"}
{"study_id": 80639, "supplement_id": 1328, "safety_score": "70", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to systematically review existing data on melatonin's effectiveness in migraine prophylaxis and provide clinical recommendations for future studies.", "results_summary": "The study found conflicting evidence on melatonin's effectiveness for migraine prevention, with some studies showing efficacy similar to other preventive medications, while others reported no difference from placebo. Observational studies supported melatonin's efficacy, but methodological limitations and high heterogeneity prevented a meta-analysis.", "population_specificity": "Patients with migraine (specific demographics not detailed).", "effective_dosage": "Immediate-release melatonin 3 mg, melatonin receptor agonist (Agomelatine) 25 mg, prolonged-release melatonin 4 mg.", "study_duration": "3 months or more (2-month trial showed ineffectiveness).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:35.376871+00:00"}
{"study_id": 80641, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to review melatonin's synthesis, function, signaling, and its potential role as an adjuvant therapeutic agent in glioma treatment.", "results_summary": "The study highlights melatonin's role in circadian rhythm regulation, energy metabolism, and its antitumor effects, particularly in glioma, suggesting its potential as an adjuvant therapy. Diminishing melatonin levels were associated with physiological and malignant conditions.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:36.221204+00:00"}
{"study_id": 80643, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the influence of melatonin on mesenchymal stem cell (MSC) biology and its potential implications for regenerative medicine.", "results_summary": "Melatonin was found to enhance MSC viability and therapeutic effects by regulating reactive oxygen species (ROS) generation and immune factor release. Biomaterials were shown to improve melatonin's protective effects on MSCs by controlling its release.", "population_specificity": "Mesenchymal stem cells (MSCs) in regenerative medicine contexts.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:37.288931+00:00"}
{"study_id": 80642, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether melatonin improves sleep quality in patients undergoing laparoscopic cholecystectomy by reducing sleep latency and increasing total sleep duration.", "results_summary": "Melatonin significantly decreased sleep latency (13.6 \u00b1 14.95 min vs. 20.10 \u00b1 16.18 min in placebo) and increased total sleep duration compared to placebo, indicating improved sleep quality post-surgery.", "population_specificity": "Patients undergoing laparoscopic cholecystectomy (100 participants).", "effective_dosage": "6 mg melatonin tablets taken 45 minutes before sleep.", "study_duration": "3 days after surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:37.291437+00:00"}
{"study_id": 80631, "supplement_id": 1328, "safety_score": "60", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the antidepressant efficacy of agomelatine, a melatonin agonist and serotonin antagonist, particularly in depression comorbid with somatic disorders.", "results_summary": "Agomelatine demonstrated efficacy in treating depression associated with Parkinson's disease, cardiovascular illness, and type II diabetes, with potential benefits for bipolar depression and seasonal affective disorder. However, long-term efficacy remains uncertain, and hepatotoxicity is a significant safety concern.", "population_specificity": "Patients with depression comorbid with somatic disorders (e.g., Parkinson's disease, cardiovascular illness, type II diabetes), bipolar depression, and seasonal affective disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:37.356299+00:00"}
{"study_id": 80644, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to assess the effectiveness of sleep interventions, including melatonin, in adults with intellectual disabilities.", "results_summary": "The study found that melatonin was effective in improving sleep in adults with intellectual disabilities, with the only low-risk-of-bias study being a placebo-controlled randomized controlled trial for melatonin. However, the overall evidence was limited by small sample sizes and heterogeneity in interventions and measurements.", "population_specificity": "Adults with intellectual disabilities (ID).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:39.647321+00:00"}
{"study_id": 80645, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate melatonin's potential as an oncostatic and antitumoral agent in skin cancer treatment, focusing on its mechanisms and synergistic effects with chemo- and radiotherapy.", "results_summary": "Melatonin demonstrated oncostatic and antitumoral properties, including anti-inflammatory effects, reactive oxygen species induction, and apoptosis regulation through specific signaling pathways. The study suggested that combining melatonin with conventional therapies could enhance therapeutic outcomes and survival in skin cancer patients.", "population_specificity": "Patients with skin cancer, particularly melanoma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:40.516665+00:00"}
{"study_id": 80646, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize evidence on melatonin's role in brain disorders and behavior, comparing findings from clinical studies, rodent models, and zebrafish neurobiology.", "results_summary": "The study highlights melatonin's involvement in brain mechanisms and disorders, with zebrafish models emerging as valuable tools for understanding its neurobiology and potential drug discovery. Parallels were drawn between zebrafish, clinical, and rodent data, emphasizing melatonin's genomic effects.", "population_specificity": "Clinical studies, rodent models, and zebrafish (Danio rerio).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:42.482426+00:00"}
{"study_id": 80647, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate melatonin's role in bone metabolism and its potential as a novel treatment for osteoporosis.", "results_summary": "Melatonin was found to both suppress bone loss and promote new bone formation by activating MT2 receptors, upregulating osteogenic genes, and inhibiting the RANKL pathway. The study suggests melatonin could serve as a biomarker and therapeutic agent for osteoporosis.", "population_specificity": "Not specified (general discussion of melatonin's effects on bone metabolism).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:43.144669+00:00"}
{"study_id": 80648, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of melatonin in reducing serum pro-inflammatory cytokines and oxidative stress markers in patients with relapsing-remitting multiple sclerosis (RRMS).", "results_summary": "Melatonin administration significantly decreased pro-inflammatory cytokines (TNF-\u03b1, IL-1\u03b2, IL-6) and oxidative stress markers (LPO, NOC) compared to placebo, but no significant difference in clinical efficacy outcomes was observed. The treatment was well tolerated with no significant differences in side effects between groups.", "population_specificity": "36 patients diagnosed with RRMS treated with Interferon \u03b2-1b (IFN\u03b2-1b).", "effective_dosage": "25 mg/d orally.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:44.731998+00:00"}
